ABSTRACT
To a quite unusual extent, the pharmaceutical industry organizes its activities along transnational lines. This is not merely true of production and marketing but also of research and development (R & D). Most large drug companies have research centres of one kind or another in a number of countries, and, to an increasing extent, the products currently arriving on the market have been developed as part of an integrated global, rather than a national or regional, innovatory programme.
